Literature DB >> 20575029

Expression of CD1d and presence of invariant NKT cells in classical Hodgkin lymphoma.

Chuanhui Xu, Riemer de Vries, Lydia Visser, Arjan Diepstra, Stephan D Gadola, Sibrand Poppema, Anke van den Berg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20575029      PMCID： PMC7159439          DOI： 10.1002/ajh.21743

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
Additional Supporting Information may be found in the online version of this article. Supplementary Table I: Expression of CD1c and CD1d in HL and NHL. Click here for additional data file.
  18 in total

1.  Evidence for human CD4+ T cells in the CD1-restricted repertoire: derivation of mycobacteria-reactive T cells from leprosy lesions.

Authors:  P A Sieling; M T Ochoa; D Jullien; D S Leslie; S Sabet; J P Rosat; A E Burdick; T H Rea; M B Brenner; S A Porcelli; R L Modlin
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

2.  CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes.

Authors:  M Exley; J Garcia; S B Wilson; F Spada; D Gerdes; S M Tahir; K T Patton; R S Blumberg; S Porcelli; A Chott; S P Balk
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

3.  Expression profiling of B cell chronic lymphocytic leukemia suggests deficient CD1-mediated immunity, polarized cytokine response, altered adhesion and increased intracellular protein transport and processing of leukemic cells.

Authors:  Z Zheng; S Venkatapathy; G Rao; C A Harrington
Journal:  Leukemia       Date:  2002-12       Impact factor: 11.528

4.  Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22.

Authors:  Marijke Niens; Lydia Visser; Ilja M Nolte; Gerrit van der Steege; Arjan Diepstra; Pablo Cordano; Ruth F Jarrett; Gerard J Te Meerman; Sibrand Poppema; Anke van den Berg
Journal:  Br J Haematol       Date:  2008-03       Impact factor: 6.998

5.  Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity.

Authors:  Chang H Kim; Brent Johnston; Eugene C Butcher
Journal:  Blood       Date:  2002-07-01       Impact factor: 22.113

6.  HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.

Authors:  Arjan Diepstra; Gustaaf W van Imhoff; Henrike E Karim-Kos; Anke van den Berg; Gerard J te Meerman; Marijke Niens; Ilja M Nolte; Esther Bastiaannet; Michael Schaapveld; Edo Vellenga; Sibrand Poppema
Journal:  J Clin Oncol       Date:  2007-05-29       Impact factor: 44.544

Review 7.  CD1: antigen presentation and T cell function.

Authors:  Manfred Brigl; Michael B Brenner
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

8.  U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma.

Authors:  A Mader; S Bruderlein; S Wegener; I Melzner; S Popov; H K Muller-Hermelink; T F Barth; A Viardot; P Moller
Journal:  Cytogenet Genome Res       Date:  2008-02-01       Impact factor: 1.636

9.  An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells.

Authors:  P Dellabona; E Padovan; G Casorati; M Brockhaus; A Lanzavecchia
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

10.  A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma.

Authors:  Madhav V Dhodapkar; Matthew D Geller; David H Chang; Kanako Shimizu; Shin-Ichiro Fujii; Kavita M Dhodapkar; Joseph Krasovsky
Journal:  J Exp Med       Date:  2003-06-09       Impact factor: 14.307
View more
  8 in total

1.  Reduced frequency of NKT-like cells in patients with progressive chronic lymphocytic leukemia.

Authors:  Farhad Jadidi-Niaragh; Mahmood Jeddi-Tehrani; Bita Ansaripour; Seyed Mohsen Razavi; Ramazan Ali Sharifian; Fazel Shokri
Journal:  Med Oncol       Date:  2012-06-06       Impact factor: 3.064

Review 2.  Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans.

Authors:  Leonid S Metelitsa
Journal:  Clin Immunol       Date:  2010-11-20       Impact factor: 3.969

3.  Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell-rich and exhausted T-effector microenvironment.

Authors:  Fathima Zumla Cader; Ron C J Schackmann; Xihao Hu; Kirsty Wienand; Robert Redd; Bjoern Chapuy; Jing Ouyang; Nicole Paul; Evisa Gjini; Mikel Lipschitz; Philippe Armand; David Wu; Jonathan R Fromm; Donna Neuberg; X Shirley Liu; Scott J Rodig; Margaret A Shipp
Journal:  Blood       Date:  2018-06-07       Impact factor: 22.113

4.  Glioma-associated oncogene homologue 3, a hedgehog transcription factor, is highly expressed in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.

Authors:  Wesley O Greaves; Ji Eun Kim; Rajesh R Singh; Elias Drakos; Kranthi Kunkalla; Beatriz Sánchez-Espiridión; Juan F Garcia; L Jeffrey Medeiros; Francisco Vega
Journal:  Hum Pathol       Date:  2011-04-29       Impact factor: 3.466

Review 5.  The regulatory role of invariant NKT cells in tumor immunity.

Authors:  Rosanna M McEwen-Smith; Mariolina Salio; Vincenzo Cerundolo
Journal:  Cancer Immunol Res       Date:  2015-05       Impact factor: 11.151

6.  CD1d expression in renal cell carcinoma is associated with higher relapse rates, poorer cancer-specific and overall survival.

Authors:  Tsung Wen Chong; Fera Yiqian Goh; Mei Yi Sim; Hong Hong Huang; Aye Aye Thike; Daw Aye Aye Thike; Weng Khong Lim; Bin Tean Teh; Puay Hoon Tan
Journal:  J Clin Pathol       Date:  2014-12-04       Impact factor: 3.411

7.  Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects.

Authors:  Luisa Lorenzi; Giovanna Tabellini; William Vermi; Daniele Moratto; Fulvio Porta; Lucia D Notarangelo; Ornella Patrizi; Silvano Sozzani; Genevieve de Saint Basile; Sylvain Latour; David Pace; Silvia Lonardi; Fabio Facchetti; Raffaele Badolato; Silvia Parolini
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

Review 8.  Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies.

Authors:  Pui Yeng Lam; Michael D Nissen; Stephen R Mattarollo
Journal:  Front Immunol       Date:  2017-10-23       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.